201 related articles for article (PubMed ID: 19861287)
21. The JUPITER Trial: responding to the critics.
Ridker PM; Glynn RJ
Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
[No Abstract] [Full Text] [Related]
22. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
Olsson AG
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
[No Abstract] [Full Text] [Related]
23. A tale of three labels: translating the JUPITER trial data into regulatory claims.
Ridker PM
Clin Trials; 2011 Aug; 8(4):417-22. PubMed ID: 21835857
[TBL] [Abstract][Full Text] [Related]
24. [The JUPITER trial: a new approach in primary prevention].
Güleç S
Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():18-26. PubMed ID: 19553758
[TBL] [Abstract][Full Text] [Related]
25. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Rosenstein R; Parra D
Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577689
[No Abstract] [Full Text] [Related]
26. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Sniderman AD
Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577690
[No Abstract] [Full Text] [Related]
27. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Feeman WE
Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577687
[No Abstract] [Full Text] [Related]
28. Rosuvastatin in patients with elevated C-reactive protein.
Jenny-Avital ER
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
[No Abstract] [Full Text] [Related]
29. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.
Ridker PM; MacFadyen JG; Glynn RJ; Chasman DI
Circ Cardiovasc Genet; 2011 Jun; 4(3):312-7. PubMed ID: 21493817
[TBL] [Abstract][Full Text] [Related]
30. Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein.
Burmeister JE; Miltersteiner DR; Campos BM
J Nephrol; 2009; 22(1):83-9. PubMed ID: 19229822
[TBL] [Abstract][Full Text] [Related]
31. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Danchin N
Lancet; 2009 Jul; 374(9683):24-5; author reply 26-7. PubMed ID: 19577685
[No Abstract] [Full Text] [Related]
32. [The JUPITER study: critical review of final results].
Urbinati S; Romanazzi S; Gambetti S
G Ital Cardiol (Rome); 2009 Dec; 10(11-12 Suppl 3):28S-32S. PubMed ID: 21298859
[TBL] [Abstract][Full Text] [Related]
33. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Segura J; Ruilope LM
Lancet; 2009 Jul; 374(9683):26; author reply 26-7. PubMed ID: 19577691
[No Abstract] [Full Text] [Related]
34. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
[No Abstract] [Full Text] [Related]
35. The risks of a new hypothesis: why did JUPITER patients have almost twice the predicted event rate of reduction?
Sgueglia GA; Crea F
J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):66-70. PubMed ID: 21139510
[TBL] [Abstract][Full Text] [Related]
36. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
Stewart RA
Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
[TBL] [Abstract][Full Text] [Related]
37. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Ridker PM;
Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
[No Abstract] [Full Text] [Related]
38. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
[TBL] [Abstract][Full Text] [Related]
39. Bringing JUPITER down to earth.
Després JP
Lancet; 2009 Apr; 373(9670):1147-8. PubMed ID: 19329179
[No Abstract] [Full Text] [Related]
40. Rosuvastatin in patients with elevated C-reactive protein.
Chan PS; Nallamothu BK; Hayward RA
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
